Novonesis Human Health Biosolutions banner featuring a young girl beside the message, “From strain to solution—helping you go seamlessly from idea to market.”
Home
BioGaia Signs New Exclusive...

BioGaia Signs New Exclusive Agreement in the UK

19 Jun 2014
Add nutritioninsight as a preferred source on Google
Image

19 Jun 2014 --- BioGaia has today extended its global contract with Nestle Nutrition by signing an agreement with the company’s UK infant nutrition business for the exclusive rights to sell BioGaia’s ProTectis Baby Drops in the United Kingdom and Ireland. Launch is planned to take place in the beginning of 2015.

Nestle Nutrition UK will market both BioGaia ProTectis Baby Drops, which is BioGaia's biggest product, and BioGaia ProTectis Baby Drops with vitamin D. Both products contain BioGaia's patented and well-documented probiotic strain Lactobacillus reuteri Protectis. Today the drops are sold in 60 countries worldwide. 

arrow

“I am delighted that we after many years of preparations have been able to conclude a contract for this large market. We have established an important key opinion leader network in the UK and the drops are already sold in a few hospital pharmacies. Considering Nestle Nutrition’s presence in the market and our preparatory work I am convinced that sales will expand quickly”, said Peter Rothschild, President, BioGaia. 

All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
Add nutritioninsight as a preferred source on Google
Save in your AIChatGPTGoogle AIClaudePerplexityGrok
Subscribe to our newsletters
PlatformsFood Ingredients FirstNutrition InsightPackaging InsightsPersonal Care InsightsThe World of Food Ingredients
About usContact usAdvertisingPrivacy statementSitemapArchive
Follow us
Image